Franklin Genomic Advancements ETF (HELX) is an ETF managed by Franklin Templeton. Its largest position is Guardant Health, Inc. (GH), representing 6.77% of fund assets.
Franklin Genomic Advancements ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- HELX
- Type:
- ETF
- Manager:
- Franklin Templeton
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 21, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
Guardant Health, Inc.
|
6.77% | $1,451,871.66 | 15,718 |
|
-
Natera, Inc.
|
6.65% | $1,426,128.69 | 7,131 |
|
-
Krystal Biotech, Inc.
|
5.32% | $1,141,257.76 | 4,418 |
|
-
UNITED THERAPEUTICS Corp
|
4.64% | $996,206.40 | 1,680 |
|
-
INSMED Inc
|
4.52% | $970,000.64 | 5,932 |
|
-
BridgeBio Pharma, Inc.
|
4.22% | $905,377.92 | 12,192 |
|
-
LIGAND PHARMACEUTICALS INC
|
3.53% | $757,472.10 | 3,794 |
|
-
ASTRAZENECA PLC
|
3.40% | $728,727.90 | 3,695 |
|
-
Adaptive Biotechnologies Corp
|
3.12% | $669,640.60 | 48,245 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
2.99% | $640,784.90 | 1,435 |
|
-
APPLIED MATERIALS INC /DE
|
2.99% | $640,229.82 | 652 |
|
-
Medpace Holdings, Inc.
|
2.97% | $637,212.13 | 1,327 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
2.69% | $577,934.72 | 748 |
|
-
Corteva, Inc.
|
2.69% | $577,933.84 | 6,904 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
2.60% | $558,177.69 | 1,687 |
|
-
ELI LILLY & Co
|
2.54% | $545,423.61 | 593 |
|
-
IONIS PHARMACEUTICALS INC
|
2.09% | $447,311.13 | 5,957 |
|
-
Tempus AI, Inc.
|
1.84% | $394,589.72 | 8,726 |
|
-
BioNTech SE
|
1.80% | $385,739.20 | 4,340 |
|
-
NEUROCRINE BIOSCIENCES INC
|
1.65% | $354,775.82 | 2,693 |
|
-
Stoke Therapeutics, Inc.
|
1.60% | $343,149.84 | 10,539 |
|
-
Twist Bioscience Corp
|
1.59% | $341,383.68 | 7,184 |
|
-
ARGENX SE
|
1.53% | $328,316.12 | 459 |
|
-
PTC THERAPEUTICS, INC.
|
1.48% | $316,940.76 | 4,652 |
|
-
Travere Therapeutics, Inc.
|
1.40% | $300,932.59 | 10,129 |
|
-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
|
1.16% | $249,262.50 | 1,445 |
|
-
CRISPR Therapeutics AG
|
1.04% | $222,199.47 | 4,671 |
|
-
REPLIGEN CORP
|
1.03% | $219,852.12 | 1,866 |
|
-
VERACYTE, INC.
|
1.02% | $218,641.48 | 6,788 |
|
-
Praxis Precision Medicines, Inc.
|
1.00% | $214,900.73 | 667 |
|
-
GRAIL, Inc.
|
1.00% | $213,851.84 | 4,138 |
|
-
SARTORIUS AG
|
0.96% | $205,331.11 | 841 |
|
-
DANAHER CORP /DE/
|
0.93% | $199,080.00 | 1,050 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
0.90% | $192,188.23 | 391 |
|
-
IQVIA HOLDINGS INC.
|
0.80% | $171,392.70 | 1,005 |
|
-
Beam Therapeutics Inc.
|
0.78% | $167,667.88 | 7,036 |
|
-
Jazz Pharmaceuticals plc
|
0.74% | $158,991.05 | 841 |
|
-
CATALYST PHARMACEUTICALS INC
|
0.74% | $157,845.00 | 6,375 |
|
-
CADENCE DESIGN SYSTEMS INC
|
0.71% | $151,439.15 | 545 |
|
-
AGILENT TECHNOLOGIES, INC.
|
0.60% | $129,481.28 | 1,136 |
|
-
CareDx, Inc.
|
0.60% | $128,967.44 | 7,429 |
|
-
QIAGEN N.V.
|
0.59% | $127,127.00 | 3,175 |
|
-
ANAPTYSBIO, INC
|
0.53% | $113,193.86 | 2,041 |
|
-
SAMSUNG EPIS HOLDINGS
|
0.53% | $112,884.80 | 350 |
|
-
Tarsus Pharmaceuticals, Inc.
|
0.49% | $104,313.05 | 1,487 |
|
-
Ultragenyx Pharmaceutical Inc.
|
0.47% | $99,826.75 | 4,765 |
|
-
Arcutis Biotherapeutics, Inc.
|
0.45% | $96,760.92 | 4,107 |
|
-
Axsome Therapeutics, Inc.
|
0.45% | $95,665.32 | 566 |
|
-
GeneDx Holdings Corp.
|
0.42% | $90,485.98 | 1,409 |
|
-
RHYTHM PHARMACEUTICALS, INC.
|
0.39% | $84,708.78 | 974 |
Advertisement (320x50)